429 related articles for article (PubMed ID: 20860495)
1. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
[TBL] [Abstract][Full Text] [Related]
2. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
[TBL] [Abstract][Full Text] [Related]
4. Growth of xenotransplanted leukemia cells is influenced by diet nutrients and is attenuated with 2-deoxyglucose.
Tsunekawa-Imai N; Miwa H; Shikami M; Suganuma K; Goto M; Mizuno S; Takahashi M; Mizutani M; Horio T; Komatsubara H; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
Leuk Res; 2013 Sep; 37(9):1132-6. PubMed ID: 23806233
[TBL] [Abstract][Full Text] [Related]
5. Adaptation of leukemia cells to hypoxic condition through switching the energy metabolism or avoiding the oxidative stress.
Goto M; Miwa H; Suganuma K; Tsunekawa-Imai N; Shikami M; Mizutani M; Mizuno S; Hanamura I; Nitta M
BMC Cancer; 2014 Feb; 14():76. PubMed ID: 24506813
[TBL] [Abstract][Full Text] [Related]
6. Opposing effects of 2-deoxy-d-glucose on interictal- and ictal-like activity when K
Nedergaard S; Andreasen M
J Neurophysiol; 2018 May; 119(5):1912-1923. PubMed ID: 29412775
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
Maher JC; Wangpaichitr M; Savaraj N; Kurtoglu M; Lampidis TJ
Mol Cancer Ther; 2007 Feb; 6(2):732-41. PubMed ID: 17308069
[TBL] [Abstract][Full Text] [Related]
8. Suppression of oxidative phosphorylation confers resistance against bevacizumab in experimental glioma.
Eriksson JA; Wanka C; Burger MC; Urban H; Hartel I; von Renesse J; Harter PN; Mittelbronn M; Steinbach JP; Rieger J
J Neurochem; 2018 Feb; 144(4):421-430. PubMed ID: 29178334
[TBL] [Abstract][Full Text] [Related]
9. Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics.
Salunkhe S; Mishra SV; Ghorai A; Hole A; Chandrani P; Dutt A; Chilakapati M; Dutt S
Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148300. PubMed ID: 32858000
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitization of tumor cells to glycolytic inhibitors.
Liu H; Hu YP; Savaraj N; Priebe W; Lampidis TJ
Biochemistry; 2001 May; 40(18):5542-7. PubMed ID: 11331019
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
[TBL] [Abstract][Full Text] [Related]
12. Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Hernlund E; Hjerpe E; Avall-Lundqvist E; Shoshan M
Mol Cancer Ther; 2009 Jul; 8(7):1916-23. PubMed ID: 19567816
[TBL] [Abstract][Full Text] [Related]
13. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization.
Hao W; Chang CP; Tsao CC; Xu J
J Biol Chem; 2010 Apr; 285(17):12647-54. PubMed ID: 20110356
[TBL] [Abstract][Full Text] [Related]
14. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
[TBL] [Abstract][Full Text] [Related]
15. Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells.
Wu L; Zhao J; Cao K; Liu X; Cai H; Wang J; Li W; Chen Z
Cell Commun Signal; 2018 Feb; 16(1):6. PubMed ID: 29402287
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
Gao C; Shen Y; Jin F; Miao Y; Qiu X
PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
[TBL] [Abstract][Full Text] [Related]
17. Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine.
Yucel B; Sonmez M
Hematology; 2018 Jul; 23(6):330-336. PubMed ID: 29139328
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines.
Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233
[TBL] [Abstract][Full Text] [Related]
19. 2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.
Wanyan Y; Xu X; Liu K; Zhang H; Zhen J; Zhang R; Wen J; Liu P; Chen Y
Molecules; 2020 Dec; 25(23):. PubMed ID: 33297583
[TBL] [Abstract][Full Text] [Related]
20. Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT-1 expression.
Maher JC; Savaraj N; Priebe W; Liu H; Lampidis TJ
Pancreas; 2005 Mar; 30(2):e34-9. PubMed ID: 15714127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]